Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma
Pheochromocytoma

Interventions

DRUG: iobenguane I 131

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]